Halozyme expanded its partnership with Argenx, adding two exclusive targets to the Enhanze drug-delivery platform. The deal now covers eight targets. Halozyme is eligible for milestone payments and royalties. CEO Helen Torley said the expansion validates Enhanze's value.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
